Anti-tumor activity of chemokine is affected by both kinds of tumors and the activation state of the host’s immune system: implications for chemokine-based cancer immunotherapy
- 1 April 2004
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 317 (1) , 68-76
- https://doi.org/10.1016/j.bbrc.2004.03.013
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health and Welfare
- Japan Health Sciences Foundation
- Japan Private School Promotion Foundation
This publication has 31 references indexed in Scilit:
- Dendritic cells transduced with gp100 gene by RGD fiber-mutant adenovirus vectors are highly efficacious in generating anti-B16BL6 melanoma immunity in miceGene Therapy, 2003
- Tumor Necrosis Factor α-Gene Therapy for an Established Murine Melanoma Using RGB (Arg-Gly-Asp) Fiber-mutant Adenovirus VectorsJapanese Journal of Cancer Research, 2002
- Chemokines: agents for the immunotherapy of cancer?Nature Reviews Immunology, 2002
- Novel immunotherapy for peritoneal dissemination of murine colon cancer with macrophage inflammatory protein-1β mediated by a tumor-specific vector, HVJ cationic liposomesCancer Gene Therapy, 2001
- Efficient Gene Delivery into Dendritic Cells by Fiber-Mutant Adenovirus VectorsBiochemical and Biophysical Research Communications, 2001
- Dendritic Cells in Cancer ImmunotherapyAnnual Review of Immunology, 2000
- A Simple Method for Constructing E1- and E1/E4-Deleted Recombinant Adenoviral VectorsHuman Gene Therapy, 1999
- Cytokine and Chemokine: A Stimulating CoupleHuman Gene Therapy, 1999
- Adenoviral Vectors Expressing Lymphotactin and Interleukin 2 or Lymphotactin and Interleukin 12 Synergize to Facilitate Tumor Regression in Murine Breast Cancer ModelsHuman Gene Therapy, 1999
- Gene therapy for metabolic disordersTrends in Genetics, 1994